Extrusion Processing of Pharmaceuticals
5.6 Conclusion and Future Perspective
144 Handbook of Polymers for Pharmaceutical Technologies
Polymers as Formulation Excipients for Hot-Melt 145 5. N. Follonier, E. Doelker, and E. Cole, Evaluation of hot-melt extrusion as a new technique
for the production of polymer-based pellets for sustained release capsules containing high loadings of freely soluble drugs, Drug Dev Ind Pharm, 20 (8), 1323–1339, 1994.
6. D.A. Miller, J.T. Mcconville, W.E.I. Yang, R.O.W. Iii, and J.W. Mcginity, Hot-melt extrusion for enhanced delivery of drug particles, J Pharm Sci, 96 (2), 361–376, 2007.
7. J. Djuris, I. Nikolakakis, S. Ibric, Z. Djuric, and K. Kachrimanis, Preparation of carbam-azepine-Soluplus solid dispersions by hot-melt extrusion, and prediction of drug-poly-mer miscibility by thermodynamic model fitting, Eur J Pharm Biopharm, 84 (1), 228–37, 2013.
8. A. Forster, J. Hempenstall, I. Tucker, and T. Rades, Selection of excipients for melt extru-sion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis, Int J Pharm, 226 (1–2), 147–61, 2001.
9. S. Shah, S. Maddineni, J. Lu, and M.A. Repka, Melt extrusion with poorly soluble drugs, Int J Pharm, 453 (1), 233–52, 2013.
10. D. Kaushik, and H. Dureja, Recent patents and patented technology platforms for pharma-ceutical taste masking, Recent Pat Drug Deliv Formul, 8 (1), 37–45, 2014.
11. H. Patil, V. Kulkarni, S. Majumdar, and M.A. Repka, Continuous manufacturing of solid lipid nanoparticles by hot melt extrusion, Int J Pharm, 471 (1–2), 153–6, Aug. 2014.
12. L. Grehan, J.A. Killion, D.M. Devine, E.K. Kenny, S. Devery, C.L. Higginbotham, and L.M.
Geever, The development of hot melt extruded biocompatible controlled release drug deliv-ery devices, Int J Polym Mater, 63 (9), 476–485, 2014.
13. W. Deng, S. Majumdar, A. Singh, S. Shah, N.N. Mohammed, S. Jo, E. Pinto, D. Tewari, T.
Durig, and M.A. Repka, Stabilization of fenofibrate in low molecular weight hydroxypro-pylcellulose matrices produced by hot-melt extrusion, Drug Dev Ind Pharm, 39 (2), 290–8, 2013.
14. S. Prodduturi, K.L. Urman, J.U. Otaigbe, and M.A. Repka, Stabilization of hot-melt extru-sion formulations containing solid solutions using polymer blends, AAPS PharmSciTech, 8 (2), Article 50, 2007.
15. C. Medina, D. Daurio, K. Nagapudi, and F. Alvarez-nunez, Manufacture of pharmaceutical co-crystals using twin screw extrusion: A solvent-less and scalable process, J Pharm Sci, 99 (4), 1693–1696, 2010.
16. R.S. Dhumal, A.L. Kelly, P. York, P.D. Coates, and A. Paradkar, Cocrystalization and simul-taneous agglomeration using hot melt extrusion, Pharm Res, 27 (12), 2725–33, 2010.
17. N.J. Babu, and A. Nangia, Solubility advantage of amorphous drugs and pharmaceutical cocrystals, Special Issue, Cryst Growth Des, 11 (7), 2662–2679, 2011.
18. G. Amidon, H. Lennernas, V. Shah, J. Crison, BCS classification system, Pharm Res, 12 (3), 413–420, 1995.
19. C.M. Wassvik, A.G. Holmén, C.A.S. Bergström, I. Zamora, and P. Artursson, Contribution of solid-state properties to the aqueous solubility of drugs, Eur J Pharm Sci, 29 (3–4), 294–
305, 2006.
20. M.D. Moore, and P.L.D. Wildfong, Aqueous solubility enhancement through engineer-ing of binary solid composites: Pharmaceutical applications, J Pharm Innov, 4 (1), 36–49, 2009.
21. C. Leuner, and J. Dressman, Improving drug solubility for oral delivery using solid disper-sions, Eur J Pharm Biopharm, 50 (1), 47–60, 2000.
22. D.Q.M. Craig, The mechanisms of drug release from solid dispersions in water-soluble polymers, Int J Pharm, 231 (2), 131–44, 2002.
23. D.D. Sun, and P.I. Lee, Evolution of supersaturation of amorphous pharmaceuticals: The effect of rate of supersaturation generation, Mol Pharm, 10, 4330–4346, 2013.
146 Handbook of Polymers for Pharmaceutical Technologies
24. H. Guzman, M. Tawa, Z. Zhang, P. Ratanabanangkoon, P. Shaw, C.R. Guzma, C.R. Gardner, H. Chen, and J. Moreau, Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations, J Pharm Sci, 96 (10), 2686–2702, 2007.
25. K. Kolter, M. Karl, and A. Gryczke, Hot-Melt Extrusion with BASF Pharma Polymers Extrusion Compendium, 2nd ed., BASF SE Pharma Ingredients & Services, Ludwigshafen, Germany, 2012.
26. M.M. Crowley, F. Zhang, M.A. Repka, S. Thumma, S.B. Upadhye, S.K. Battu, J.W. McGinity, and C. Martin, Pharmaceutical applications of hot-melt extrusion: Part I, Drug Dev Ind Pharm, 33 (9), 909–26, 2007.
27. D.J. Greenhalgh, A.C. Williams, P. Timmins, and P. York, Solubility parameters as predic-tors of miscibility in solid dispersions, J Pharm Sci, 88 (11), 1182–90, 1999.
28. F. Qian, J.U.N. Huang, and M.A. Hussain, Drug–polymer solubility and miscibility : Stability consideration and practical challenges in amorphous solid dispersion develop-ment, J Pharm Sci, 99 (7), 2941–2947, 2010.
29. Y. Tian, J. Booth, E. Meehan, D.S. Jones, S. Li, and G.P. Andrews, Construction of drug-poly-mer thermodynamic phase diagrams using Flory-Huggins interaction theory: Identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions, Mol Pharm, 10 (1), 236–48, 2013.
30. M. Rubinstein, and R. Colby, Polymer Physics, New York, NY: Oxford University Press Inc., 2003.
31. R. Koningsveld, W.H. Stockmayer, and E. Nies, Polymer Phase Diagrams: A Textbook, Oxford: Oxford University Press Inc., 360 pp., 2001.
32. D.W. van Krevelen, and K. Te Nijenhuis, Properties of Polymers, 4th ed. Elsevier, Amsterdam, The Netherlands, 1030 pp., 2009.
33. R.F. Fedors, A method for estimating both the solubility parameters and molar volumes of liquids. Polym Eng Sci, 14 (6), 472–472, 1974.
34. P.J. Marsac, S.L. Shamblin, and L.S. Taylor, Theoretical and practical approaches for predic-tion of drug-polymer miscibility and solubility, Pharm Res, 23 (10), 2417–26, 2006.
35. D. Law, W. Wang, E.A. Schmitt, and M.A. Long, Prediction of poly(ethylene) glycol-drug eutectic compositions using an index based on the van’t Hoff equation, Pharm Res, 19 (3), 315–321, 2002.
36. N. Pilpel, The flow properties of magnesia, J Pharm Pharmacol, 16, 705–716, 1964.
37. C. Rauwendaal, Understanding Extrusion, 2nd ed., Hanser Publications, 2010.
38. M. Ahmad, and N. Pilpel, Flow of granular solids through horizontal orifices, Rheol Acta, 8 (4), 448–456, 1969.
39. K. Luker, “Single-screw extrusion and screw design,” in: I. Ghebre-Sellassie, and C. Martin, eds., Pharmaceutical Extrusion Technology, Taylor & Francis, pp. 36–62, 2003.
40. W. Doetsch, “Material handling and feeder technology,” in: I. Ghebre-Sellassie, and C.
Martin, eds., Pharmaceutical Extrusion Technology, Taylor & Francis, pp. 101–124, 2003.
41. R. Carr, Particle behaviour storage and flow, Br Chem Eng, 70, 1541–1549, 1970.
42. P. Lafleur, and B. Vergnes, Polymer Extrusion, Wiley, 2014.
43. H. Giles, J. Wagner, and E. Mount, Extrusion: The Definitive Processing Guide, William Andrew, 2005.
44. A. Dreiblatt, “Process design,” in: I. Ghebre-Selassie, and C. Martin, eds., Pharmaceutical Extrusion Technology, Taylor & Francis, pp. 140–154, 2003.
45. R. Steiner, “Extruder design,” in: I. Ghebre-Sellassie, and C. Martin, eds., Pharmaceutical Extrusion Technology, Taylor & Francis, pp. 17–35, 2003.
Polymers as Formulation Excipients for Hot-Melt 147 46. J.M. Keen, C. Martin, A. Machado, H. Sandhu, J.W. McGinity, and J.C. DiNunzio,
Investigation of process temperature and screw speed on properties of a pharmaceuti-cal solid dispersion using corotating and counter-rotating twin-screw extruders, J Pharm Pharmacol, 66 (2), 204–217, 2014.
47. L.A. Wegiel, L.J. Mauer, K.J. Edgar, and L.S. Taylor, Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions, J Pharm Pharmacol, 66 (2), 244–55, 2014.
48. M. Bounartzi, A. Panagopoulou, N. Kantiranis, S. Malamataris, and I. Nikolakakis, Effect of plasticiser type on the hot melt extrusion of venlafaxine hydrochloride, J Pharm Pharmacol, 66 (2), 297–308, 2014.
49. C. Bruce, K.A. Fegely, A.R. Rajabi-Siahboomi, and J.W. McGinity, Crystal growth formation in melt extrudates, Int J Pharm, 341 (1–2), 162–72, 2007.
50. T. Fox, and P. Flory, Further studies on the melt viscosity of polyisobutylene, J Phys Colloid Chem, 55 (2), 221–234, 1948.
51. B.M. Karl, D. Djuric, and K. Kolter, Pharmaceutical excipients for hot-melt extrusion, Pharm Technol, 35 (5), 74–82, 2011.
52. J. Dealy, and J. Wang, Melt Rheology and Its Applications in the Plastics Industry, 2nd ed., Springer, New York, 2013.
53. U. Quintavalle, D. Voinovich, B. Perissutti, F. Serdoz, G. Grassi, A. Dal Col, and M. Grassi, Preparation of sustained release co-extrudates by hot-melt extrusion and mathematical modelling of in vitro/in vivo drug release profiles, Eur J Pharm Sci, 33 (3), 282–93, 2008.
54. L. Dierickx, L. Saerens, A. Almeida, T. De Beer, J.P. Remon, and C. Vervaet, Co-extrusion as manufacturing technique for fixed-dose combination mini-matrices, Eur J Pharm Biopharm, 81 (3), 683–9, 2012.
55. L. Dierickx, J.P. Remon, and C. Vervaet, Co-extrusion as manufacturing technique for mul-tilayer mini-matrices with dual drug release, Eur J Pharm Biopharm, 85, (3 Pt B), 1157–63, 2013.
56. A.-K. Vynckier, L. Dierickx, J. Voorspoels, Y. Gonnissen, J.P. Remon, and C. Vervaet, Hot-melt co-extrusion: Requirements, challenges and opportunities for pharmaceutical applica-tions, J Pharm Pharmacol, 66 (2), 167–79, 2014.
57. M.M. Crowley, F. Zhang, J.J. Koleng, and J.W. McGinity, Stability of polyethylene oxide in matrix tablets prepared by hot-melt extrusion, Biomaterials, 23 (21), 4241–8, 2002.
58. F. Zhang, and J.W. McGinity, Properties of sustained-release tablets prepared by hot-melt extrusion, Pharm Dev Technol, 4 (2), 241–50, 1999.
59. T. Kipping, and H. Rein, A new method for the continuous production of single dosed controlled release matrix systems based on hot-melt extruded starch: Analysis of relevant process parameters and implementation of an in-process control, Eur J Pharm Biopharm, 84 (1), 156–71, 2013.
60. J. Chen, Y. Chen, H. Li, S.Y. Lai, and J. Jow, Physical and chemical effects of ultrasound vibration on polymer melt in extrusion, Ultrason Sonochem, 17 (1), 66–71, 2010.
61. H. Liu, Z. Linjie, P. Wang, X. Zhang, and C. Gogos, Effects of screw configuration on indomethacin dissolution behavior in Eudragit E PO, Adv Polym Technol, 31 (4), 331–342, 2011.
62. F. Yun, A. Kang, J. Shan, X. Zhao, X. Bi, J. Li, and L. Di, Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement, Int J Pharm, 465 (1–2), 436–43, 2014.
63. C. De Brabander, G. Van Den Mooter, C. Vervaet, and J.P. Remon, Characterization of ibu-profen as a nontraditional plasticizer of ethyl cellulose, J Pharm Sci, 91 (7), 1678–85, 2002.
148 Handbook of Polymers for Pharmaceutical Technologies
64. X. Zheng, R. Yang, X. Tang, and L. Zheng, Part I: Characterization of solid dispersions of nimodipine prepared by hot-melt extrusion, Drug Dev Ind Pharm, 33 (7), 791–802, 2007.
65. G.P. Andrews, O.A. AbuDiak, and D.S. Jones, Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions, J Pharm Sci, 99 (3), 1322–
35, 2010.
66. J.R. Hughey, J.M. Keen, C. Brough, S. Saeger, and J.W. McGinity, Thermal processing of a poorly water-soluble drug substance exhibiting a high melting point: The utility of KinetiSol® Dispersing, Int J Pharm, 419 (1–2), 222–30, 2011.
67. S.K. Sathigari, V.K. Radhakrishnan, V.A. Davis, D.L. Parsons, and R.J. Babu, Amorphous-state characterization of efavirenz-polymer hot-melt extrusion systems for dissolution enhancement, J Pharm Sci, 101 (9), 3456–64, 2012.
68. I. Ghosh, J. Snyder, R. Vippagunta, M. Alvine, R. Vakil, W.-Q. Tong, and S. Vippagunta, Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder, Int J Pharm, 419 (1–2), 12–19, 2011.
69. S.M. Maru, M. de Matas, A. Kelly, and A. Paradkar, Characterization of thermal and rheo-logical properties of zidovudine, lamivudine and plasticizer blends with ethyl cellulose to assess their suitability for hot melt extrusion, Eur J Pharm Sci, 44 (4), 471–8, 2011.
70. R.J. Chokshi, H.K. Sandhu, R.M. Iyer, N.H. Shah, A.W. Malick, and H. Zia, Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitabil-ity for hot-melt extrusion processs as a means to manufacture solid dispersion/solution, J Pharm Sci, 94 (11), 2463–74, 2005.
71. S.U. Schilling, N.H. Shah, A. Waseem Malick, and J.W. McGinity, Properties of melt extruded enteric matrix pellets, Eur J Pharm Biopharm, 74 (2), 352–61, 2010.
72. C.R. Young, J.J. Koleng, and J.W. McGinity, Production of spherical pellets by a hot-melt extrusion and spheronization process, Int J Pharm, 242 (1–2), 87–92, 2002.
73. E. Mehuys, J.-P. Remon, and C. Vervaet, Production of enteric capsules by means of hot-melt extrusion, Eur J Pharm Sci, 24 (2–3), 207–12, 2005.
74. L.D. Bruce, N.H. Shah, A.W. Malick, M.H. Infeld, and J.W. McGinity, Properties of hot-melt extruded tablet formulations for the colonic delivery of 5-aminosalicylic acid, Eur J Pharm Biopharm, 59 (1), 85–97, 2005.
75. Y. Zhu, N.H. Shah, A.W. Malick, M.H. Infeld, and J.W. McGinity, Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers, Drug Dev Ind Pharm, 32 (5), 569–83, 2006.
76. Y. Zhu, K.A. Mehta, and J.W. McGinity, Influence of plasticizer level on the drug release from sustained release film coated and hot-melt extruded dosage forms, Pharm Dev Technol, 11 (3), 285–94, 2006.
77. A.N. Ghebremeskel, C. Vemavarapu, and M. Lodaya, Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: Stability testing of selected solid disper-sions, Pharm Res, 23 (8), 1928–36, 2006.
78. D.A. Miller, J.C. DiNunzio, W. Yang, J.W. McGinity, and R.O. Williams, Targeted intestinal delivery of supersaturated itraconazole for improved oral absorption, Pharm Res, 25 (6), 1450–9, 2008.
79. S.U. Schilling, N.H. Shah, A.W. Malick, M.H. Infeld, and J.W. McGinity, Citric acid as a solid-state plasticizer for Eudragit RS PO, J Pharm Pharmacol, 59 (11), 1493–1500, 2007.
80. A. Almeida, S. Possemiers, M.N. Boone, T. De Beer, T. Quinten, L. Van Hoorebeke, J.P.
Remon, and C. Vervaet, Ethylene vinyl acetate as matrix for oral sustained release dosage forms produced via hot-melt extrusion, Eur J Pharm Biopharm, 77 (2), 297–305, 2011.
81. R. Yang, Y. Wang, X. Zheng, J. Meng, X. Tang, and X. Zhang, Preparation and evaluation of ketoprofen hot-melt extruded enteric and sustained-release tablets, Drug Dev Ind Pharm, 34 (1), 83–89, 2008.
Polymers as Formulation Excipients for Hot-Melt 149 82. E. Verhoeven, T.R.M. De Beer, G. Van den Mooter, J.P. Remon, and C. Vervaet, Influence
of formulation and process parameters on the release characteristics of ethylcellulose sus-tained-release mini-matrices produced by hot-melt extrusion, Eur J Pharm Biopharm, 69 (1), 312–319, 2008.
83. J. DiNunzio, F. Zhang, C. Martin, and J. McGinity, “Melt extrusion,” in: R. Williams III, A.
Watts, and D. Miller, eds., Formulating Poorly Water Soluble Drugs, Springer, New York, pp.
311-362, 2012.
151
Vijay Kumar Thakur and Manju Kumari Thakur, Handbook of Polymers for Pharmaceutical Technologies, Volume 2 (151–172) © 2015 Scrivener Publishing LLC
*Corresponding author: [email protected]